A multidisciplinary approach to coronavirus disease (Covid?19)

dc.contributor.authorGediz Erturk, Aliye
dc.contributor.authorŞahin, Arzu
dc.contributor.authorAy, Ebru Batı
dc.contributor.authorPelit, Emel
dc.contributor.authorBağdatli, Emine
dc.contributor.authorKulu, Irem
dc.contributor.authorGül, Melek
dc.date.accessioned2025-10-29T12:09:57Z
dc.date.issued2021
dc.departmentGebze Teknik Üniversitesi
dc.description.abstractSince December 2019, humanity has faced an important global threat. Many studies have been published on the origin, structure, and mechanism of action of the SARS?CoV?2 virus and the treatment of its disease. The priority of scientists all over the world has been to direct their time to research this subject. In this review, we highlight chemical studies and therapeutic approaches to overcome COVID?19 with seven different sections. These sections are the structure and mechanism of action of SARS?CoV?2, immunotherapy and vaccine, computer?aided drug design, repurposing therapeutics for COVID?19, synthesis of new molecular structures against COVID?19, food safety/security and functional food components, and potential natural products against COVID?19. In this work, we aimed to screen all the newly synthesized compounds, repurposing chemicals cov-ering antiviral, anti?inflammatory, antibacterial, antiparasitic, anticancer, antipsychotic, and anti-histamine compounds against COVID?19. We also highlight computer?aided approaches to develop an anti?COVID?19 molecule. We explain that some phytochemicals and dietary supplements have been identified as antiviral bioproducts, which have almost been successfully tested against COVID?19. In addition, we present immunotherapy types, targets, immunotherapy and inflamma-tion/mutations of the virus, immune response, and vaccine issues. © 2021 Elsevier B.V., All rights reserved.
dc.identifier.doi10.3390/molecules26123526 [2]
dc.identifier.issn1420-3049
dc.identifier.issue12
dc.identifier.scopus2-s2.0-85108350321
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.3390/molecules26123526 [2]
dc.identifier.urihttps://hdl.handle.net/20.500.14854/14839
dc.identifier.volume26
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherMDPI AG
dc.relation.ispartofMolecules
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_Scopus_20251020
dc.subjectCOVID?19
dc.subjectCytokine storm
dc.subjectDietary supplements
dc.subjectImmunotherapy
dc.subjectIn?silico research
dc.subjectNatural products
dc.subjectRepurposing drugs
dc.subjectSARS?CoV?2
dc.subjectSmall drugs
dc.subjectVaccine development
dc.titleA multidisciplinary approach to coronavirus disease (Covid?19)
dc.typeReview Article

Dosyalar